BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26956379)

  • 21. Utility of Multimodality Approach Including Systemic FGF23 Venous Sampling in Localizing Phosphaturic Mesenchymal Tumors.
    Kato H; Koga M; Kinoshita Y; Hidaka N; Hoshino Y; Takashi Y; Arai M; Kobayashi H; Katsura M; Nakamoto Y; Makise N; Ushiku T; Hoshi K; Nangaku M; Makita N; Fukumoto S; Ito N
    J Endocr Soc; 2022 Dec; 7(2):bvac181. PubMed ID: 36540156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Challenges in Diagnosis, Tumor Localization and Treatment of Tumor-Induced Osteomalacia: Outcome of a Retrospective Surveillance.
    Hidaka N; Koga M; Kimura S; Hoshino Y; Kato H; Kinoshita Y; Makita N; Nangaku M; Horiguchi K; Furukawa Y; Ohnaka K; Inagaki K; Nakagawa A; Suzuki A; Takeuchi Y; Fukumoto S; Nakatani F; Ito N
    J Bone Miner Res; 2022 Aug; 37(8):1479-1488. PubMed ID: 35690913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locally aggressive and multifocal phosphaturic mesenchymal tumors: two unusual cases of tumor-induced osteomalacia.
    Higley M; Beckett B; Schmahmann S; Dacey E; Foss E
    Skeletal Radiol; 2015 Dec; 44(12):1825-31. PubMed ID: 26341245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Rare Association Between Osteomalacia, Phosphaturic Mesenchymal Tumor, and Ovarian Cancer: A Case Report and Literature Review.
    Mazza M; Arcidiacono GP; Hoxhaj I; Padoan V; Tasca G; Burei M; Sella S; Simioni P; Giannini S; Mocellin S
    Calcif Tissue Int; 2024 May; ():. PubMed ID: 38806758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-induced osteomalacia treated with T12 tumor resection.
    Mancini AJ; Sabet A; Nielsen GP; Parker JA; Schwab JH; Ward A; Wu JS; Malabanan AO
    Endocrinol Diabetes Metab Case Rep; 2022 Dec; 2022():. PubMed ID: 36511458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis.
    Wasserman JK; Purgina B; Lai CK; Gravel D; Mahaffey A; Bell D; Chiosea SI
    Head Neck Pathol; 2016 Sep; 10(3):279-85. PubMed ID: 26759148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia.
    Kobayashi K; Imanishi Y; Koshiyama H; Miyauchi A; Wakasa K; Kawata T; Goto H; Ohashi H; Koyano HM; Mochizuki R; Miki T; Inaba M; Nishizawa Y
    Life Sci; 2006 Apr; 78(20):2295-301. PubMed ID: 16337659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-Induced Osteomalacia.
    Florenzano P; Hartley IR; Jimenez M; Roszko K; Gafni RI; Collins MT
    Calcif Tissue Int; 2021 Jan; 108(1):128-142. PubMed ID: 32504138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical, morphological and immunohistochemical analysis of 13 cases of phosphaturic mesenchymal tumor - A holistic diagnostic approach.
    Chatterjee D; Bardia A; Pal R; Saikia UN; Bhadada SK; Radotra BD
    Ann Diagn Pathol; 2021 Oct; 54():151783. PubMed ID: 34329884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphaturic mesenchymal tumors: what an endocrinologist should know.
    Boland JM; Tebben PJ; Folpe AL
    J Endocrinol Invest; 2018 Oct; 41(10):1173-1184. PubMed ID: 29446010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.
    Folpe AL; Fanburg-Smith JC; Billings SD; Bisceglia M; Bertoni F; Cho JY; Econs MJ; Inwards CY; Jan de Beur SM; Mentzel T; Montgomery E; Michal M; Miettinen M; Mills SE; Reith JD; O'Connell JX; Rosenberg AE; Rubin BP; Sweet DE; Vinh TN; Wold LE; Wehrli BM; White KE; Zaino RJ; Weiss SW
    Am J Surg Pathol; 2004 Jan; 28(1):1-30. PubMed ID: 14707860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphaturic Mesenchymal Tumors in the Head and Neck Demonstrate a Broad Clinical and Morphologic Spectrum.
    Hulme KR; Mahar A; Campbell RG; Clifton-Bligh R; Gill AJ; Palme CE; Gupta R
    Head Neck Pathol; 2022 Sep; 16(3):902-912. PubMed ID: 35119617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimodality Image-Guided Cryoablation for Inoperable Tumor-Induced Osteomalacia.
    Tella SH; Amalou H; Wood BJ; Chang R; Chen CC; Robinson C; Millwood M; Guthrie LC; Xu S; Levy E; Krishnasamy V; Gafni RI; Collins MT
    J Bone Miner Res; 2017 Nov; 32(11):2248-2256. PubMed ID: 28718983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Octreotide Is Ineffective in Treating Tumor-Induced Osteomalacia: Results of a Short-Term Therapy.
    Ovejero D; El-Maouche D; Brillante BA; Khosravi A; Gafni RI; Collins MT
    J Bone Miner Res; 2017 Aug; 32(8):1667-1671. PubMed ID: 28459498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphaturic mesenchymal tumor (PMT): exceptionally rare disease, yet crucial not to miss.
    Ghorbani-Aghbolaghi A; Darrow MA; Wang T
    Autops Case Rep; 2017; 7(3):32-37. PubMed ID: 29043208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Utility of Somatostatin Receptor 2A Immunohistochemistry for Tumor-induced Osteomalacia.
    Lee S; Hong N; Shin S; Kim SI; Yun M; Kim SK; Rhee Y
    J Clin Endocrinol Metab; 2022 May; 107(6):1609-1615. PubMed ID: 35184184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphaturic mesenchymal tumors: A review and update.
    Folpe AL
    Semin Diagn Pathol; 2019 Jul; 36(4):260-268. PubMed ID: 31301876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tumor-induced osteomalacia caused by an FGF23-secreting myopericytoma : Case report and literature review].
    Muro Bushart N; Tharun L; Oheim R; Paech A; Kiene J
    Orthopade; 2020 Jan; 49(1):1-9. PubMed ID: 30937490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-induced osteomalacia: experience from a South American academic center.
    González G; Baudrand R; Sepúlveda MF; Vucetich N; Guarda FJ; Villanueva P; Contreras O; Villa A; Salech F; Toro L; Michea L; Florenzano P
    Osteoporos Int; 2017 Jul; 28(7):2187-2193. PubMed ID: 28341900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Definitive surgical treatment of osteomalacia induced by skull base tumor and determination of the half-life of serum fibroblast growth factor 23.
    Hana T; Tanaka S; Nakatomi H; Shojima M; Fukumoto S; Ikemura M; Saito N
    Endocr J; 2017 Oct; 64(10):1033-1039. PubMed ID: 28768937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.